መነሻ › የጡንቻ ካንሰር › ኮነቲከት › Bridgeport
በBridgeport፣ CT ለየጡንቻ ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች
ለየጡንቻ ካንሰር የሚደረጉ 21 ጥናቶች በBridgeport እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
- Stony Brook University Medical Center, Stony Brook · 18 ማይል ርቀት
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Stony Brook University-Cancer Center ( Site 0034), Stony Brook · 18 ማይል ርቀት
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Research Site, Stony Brook · 18 ማይል ርቀት
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Smilow Cancer Hospital Care Center - Trumbull, Trumbull · 4 ማይል ርቀት
- Smilow Cancer Hospital Care Center - Fairfield, Fairfield · 5 ማይል ርቀት
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
ተሳታዮችን በመፈለግ ላይ
- Stony Brook Cancer Center, Stony Brook · 18 ማይል ርቀት
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Stony Brook University Hospital, Stony Brook · 18 ማይል ርቀት
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Stony Brook University Medical Center, Stony Brook · 18 ማይል ርቀት
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Stony Brook University Cancer Center, Stony Brook · 18 ማይል ርቀት
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
ተሳታዮችን በመፈለግ ላይደረጃ 3
- New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C. (Port Jefferson Station2), Port Jefferson Station · 19 ማይል ርቀት
- New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C.(Port Jefferson Station1), Port Jefferson Station · 19 ማይል ርቀት
- New York Cancers & Blood Specialists, Port Jefferson Station · 19 ማይል ርቀት
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Hartford HealthCare - Saint Vincent's Medical Center, Bridgeport
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 4 ማይል ርቀት
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 5 ማይል ርቀት
- እና 1 ተጨማሪ
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Stony Brook Cancer Center, Stony Brook · 18 ማይል ርቀት
ATEMPT 2.0: Adjuvant T-DM1 vs TH
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Smilow Cancer Hospital Care center at Trumbull, Trumbull · 4 ማይል ርቀት
- Smilow Cancer Hospital Care center at Fairfield, Fairfield · 5 ማይል ርቀት
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1
- New York Cancer and Blood Specialists, Port Jefferson Station · 19 ማይል ርቀት
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Stony Brook University Cancer Center, Stony Brook · 18 ማይል ርቀት
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Smilow Cancer Hospital - Fairfield, Fairfield · 5 ማይል ርቀት
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 4 ማይል ርቀት
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 5 ማይል ርቀት
- Stony Brook University Medical Center, Stony Brook · 18 ማይል ርቀት
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Stony Brook Medicine, Stony Brook · 18 ማይል ርቀት
Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer
ተሳታዮችን በመፈለግ ላይየመጀመሪያ ደረጃ 1
- Stony Brook Breast Center, Stony Brook · 18 ማይል ርቀት
Definitive Radiation Therapy for Inoperable Breast Cancer
ተሳታዮችን በመፈለግ ላይ
- Stony Brook University Cancer Center, Stony Brook · 18 ማይል ርቀት
Definitive Radiation for High-Risk Spine Metastases
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Stony Brook University Hospital, Stony Brook · 18 ማይል ርቀት
CtDNA Based MRD Testing for NAC Monitoring in TNBC
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Stony Brook University Cancer Center, Stony Brook · 18 ማይል ርቀት
በሌሎች ከተሞች ለየጡንቻ ካንሰር የሚደረጉ ጥናቶች
- New York City, NY136 ጥናቶች
- Houston, TX126 ጥናቶች
- Boston, MA112 ጥናቶች
- Nashville, TN81 ጥናቶች
- Los Angeles, CA73 ጥናቶች
- Edison, NJ68 ጥናቶች
- St. Louis, MO64 ጥናቶች
- Queens, NY64 ጥናቶች
- Durham, NC64 ጥናቶች
- Chicago, IL59 ጥናቶች
- Philadelphia, PA56 ጥናቶች
- Dallas, TX55 ጥናቶች
በBridgeport ውስጥ ያሉ ሌሎች ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር14 ጥናቶች
- የሳንባ ካንሰር13 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ12 ጥናቶች
- የልብና የደም ዝውውር ሕመም9 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)8 ጥናቶች
- የራስ እና የአንገት ስኩዋመስ ሴል ካርሲኖማ8 ጥናቶች
- Metastatic Cancer7 ጥናቶች
- የልብ ድካም7 ጥናቶች
- የአንጎት አኒውሪዝም6 ጥናቶች
- Multiple Myeloma6 ጥናቶች
- የፕሮስቴት ካንሰር6 ጥናቶች
- የእንቁላል ካንሰር5 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።